Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

Clinical trial NCT06224660 · RECRUITING

Trial details

NCT number: NCT06224660
Sponsor: Sardocor Corp.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

DMD-Associated Dilated Cardiomyopathy

Start date: 2024-10-02
Primary completion: 2027-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.